WEDNESDAY, June 14, 2023 (HealthDay News) — Most women diagnosed with early breast cancer will become long-term survivors, according to new research that finds a substantial reduction in the risk of death since the 1990s. This news should reassure both patients and their doctors, researchers report June 13 in theContinue Reading
WEDNESDAY, June 14, 2023 (HealthDay News) — The lung cancer drug alectinib (Alecensa) is more potent when taken with a fuller breakfast, or lunch, than when taken with a low-fat breakfast, researchers report. The Dutch team evaluated 20 patients who took one of two daily doses of alectinib with eitherContinue Reading
TUESDAY, June 13, 2023 (HealthDay News) — Sometimes women who survive breast cancer will die from a second cancer, and now new research suggests the risk of that happening is higher for Black and Hispanic survivors than white women. “We believe this to be one of the first studies toContinue Reading
MONDAY, June 12, 2023 (HealthDay News) — Patients with bile duct cancer might soon have an additional treatment available to them, thanks to a newly discovered tumor target. Some bile duct cancers are driven by a mutated HER2 gene, which has also been implicated in cancers of the breast, esophagusContinue Reading
FRIDAY, June 9, 2023 (HealthDay News) — For patients battling late-stage lung cancer, prospects for survival have improved significantly since the advent of medications known as immune checkpoint inhibitors. But exactly how long patients with advanced non-small cell lung cancer (NSCLC) need to be on immunotherapy has not been known.Continue Reading
FRIDAY, June 9, 2023 (HealthDay News) — The percentage of cancer survivors who struggle with a disability has doubled in the past 20 years, new research shows. “The fact that we are saving more lives from cancer is worth celebrating, but it also warrants a shift toward understanding and improvingContinue Reading
THURSDAY, June 8, 2023 (HealthDay News) – A new survey of cancer centers find that chemotherapy shortages are affecting most of them, prompting last-minute changes in treatment for numerous types of cancer. About 93% of the centers surveyed said they were experiencing shortages of the drug carboplatin, while 70% wereContinue Reading
WEDNESDAY, June 7, 2023 (HealthDay News) — Folks who are loaded down with medical debt are less likely to survive a bout of cancer, a new study reports. Researchers found that U.S. counties where more residents have medical debt in collections also had more cancer deaths, compared to counties withContinue Reading
TUESDAY, June 6, 2023 (HealthDay News) — Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows. The results could have major implications for patients whose cancers carry a mutationContinue Reading
TUESDAY, June 6, 2023 (HealthDay News) — Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows. One trial found that rectal cancer patients whose tumors shrink in response to chemotherapy canContinue Reading